Ambit Biosciences Company

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Technology: Immunotherapy
Industry: PharmTech
Headquarters: San Diego, California, United States
Founded Date: 2000
Employees Number: 51-100
Funding Status: M&A
Investors Number: 15
Total Funding: 215727869 USD
Estimated Revenue: $10M to $50M
Last Funding Date: 2012-11-06
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership